New program aims to keep young diabetics on track with glucose monitoring
NCT ID NCT05854069
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 29 times
Summary
This study tests a program called FAMS that helps young adults aged 18-24 with type 1 diabetes use their continuous glucose monitor (CGM) more often. Participants include 140 CGM users who also have high blood sugar or diabetes distress. The goal is to see if the program reduces gaps in CGM use and improves how they respond to glucose data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.